Top compounds associated with response to C20orf141


Feature Type Standardized
Nominal ANOVA
mRNA TAE684 CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA decitabine CTRPv2 pan-cancer AAC -0.087 0.001
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.001
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.002
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.002
mRNA NPC-26 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.082 0.009
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.01
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.01
mRNA Erlotinib gCSI pan-cancer AAC 0.14 0.01
Download CSV